Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LaFleur Minerals Provides Update on Beacon Mill Restart and Exploration Updates (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hoth Therapeutics Inc HOTH

Healthcare Biotechnology
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HOTH)

Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment

PR Newswire 3 days ago

Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer Patients in Need

PR Newswire 11 days ago

Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American Academy of Dermatology 2025 Annual Meeting

PR Newswire March 5, 2025

Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease

PR Newswire March 4, 2025

Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic

PR Newswire February 10, 2025

Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements

PR Newswire January 24, 2025

Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications

PR Newswire January 21, 2025

Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

PR Newswire January 17, 2025

Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries

PR Newswire January 8, 2025
View More News ››

Opinion & Analysis (NDAQ:HOTH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:HOTH)

HOTH

2025-03-04 18:08:00 GMT DJ Hoth Therapeutics Price Target Maintained With a $5.00/Share by D. Boral Capital
7Twiggy - March 4, 2025

RE:HOTH ....ripping on NR

Like I said....Til it doesn't ; )
Iseneschal - January 7, 2025

HOTH ....ripping on NR

Til it doesn't
Iseneschal - January 7, 2025

I am looking for a home run

They are involved in cancer therapies, weight loss control, alzheimers, just to name a few.  Any one of these programs could hit...
7Twiggy - January 1, 2025

Tax loss selling over

Tax selling over.  My hope is we will see two or more big announcements that hould move the stock to triple digits.
7Twiggy - December 31, 2024

Promising results on a number of fronts, alzheimer's, skin c

The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001)...
7Twiggy - November 1, 2024
View more Bullboard ››

Prospera Energy Inc.

Prospera Energy Inc.

Prospera Energy Inc. is an energy company based in Western Canada, specializing in the exploration, development, and ...
View More »